US 10420748
Methods of treatment associated with the granulocyte colony-stimulating factor receptor
granted A61KA61K31/40A61K31/4015
Quick answer
US patent 10420748 (Methods of treatment associated with the granulocyte colony-stimulating factor receptor) held by Ligand Pharmaceuticals Incorporated expires Mon Sep 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ligand Pharmaceuticals Incorporated
- Grant date
- Tue Sep 24 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K31/40, A61K31/4015, A61K31/4045, A61K31/41